Opening Ceremony

Date & Time

Pre-eventOct. 29, 2026 (Thu) 10:00 ~ 10:30

CeremonyOct. 29, 2026 (Thu) 10:30 ~ 12:00

Venue

Global Edu Hall, 1F, National Institute for International Education

Participants

Approx. 1,000 biohealth professionals from Korea and abroad

Oct. 29, 2026 (Thu) 11:05 ~ 12:00 | Global Edu Hall, National Institute for International Education

Jimmy Yen-Chu Lin

Founder & CEO, Vernus AI

Oct. 29, 2026 (Thu) 11:05 ~ 11:35

AI Found the Molecule. Now What? From AI Drug Discovery to Global Biohealth Business

- Explore how advances in AI-driven drug discovery and manufacturing technologies are transforming the biohealth industry and business models, and examine the strategies and ecosystem needed to turn technological innovation into commercialization and global business opportunities.

Key Experience

Founder & CEO, Vernus AI
Former CEO, Insilico Medicine Taiwan
Adjunct Professor, College of Pharmacy, National Yang Ming Chiao Tung University
AI drug discovery specialist with expertise in AI-driven drug discovery (AIDD), computer-aided drug design (CADD), pharmacology, and chemical biology
Former Professor, School of Pharmacy, National Taiwan University; former Ph.D. researcher at ETH Zurich; research experience at Harvard University and A*STAR

JiHee Noh

Country Manager Korea,
HiRO Korea

Oct. 29, 2026 (Thu) 11:35 ~ 12:00

From Drug Innovation to Global Success: Clinical and Regulatory Strategies for Commercialization

- Explore the global clinical and regulatory strategies and partnerships needed for Korean biohealth companies to translate technological competitiveness into successful global market entry and business outcomes, and identify how companies can better position themselves for success in global markets.

Key Experience

Country Manager & Director, Regulatory Affairs and Strategy, HiRO Korea
Global Regulatory Leader for Multi-Regional Clinical Trials
Licensed Pharmacist, M.Sc. Pharmacy, Ewha Womans University
Ph.D. Candidate, Pharmacy, Chung-Ang University